Cargando…

Interleukin-37: associations of plasma levels and genetic variants in gout

OBJECTIVES: IL-37 is an anti-inflammatory cytokine involved in inflammatory and autoimmune diseases. We aimed to investigate the association between IL-37 genetic variants, IL-37 plasma levels, and various clinical phases of gout. METHODS: The study included a control group with no history of primar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andres Cerezo, Lucie, Navrátilová, Adéla, Hulejová, Hana, Pavlíková, Markéta, Závada, Jakub, Pavelka, Karel, Šenolt, Ladislav, Stiburkova, Blanka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583385/ https://www.ncbi.nlm.nih.gov/pubmed/37853488 http://dx.doi.org/10.1186/s13075-023-03188-3

Ejemplares similares

Interaction of the p.Q141K Variant of the ABCG2 Gene with Clinical Data and Cytokine Levels in Primary Hyperuricemia and Gout
por: Horváthová, Veronika, et al.
Publicado: (2019)

The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients
por: Stiburkova, Blanka, et al.
Publicado: (2019)

New pro-inflammatory cytokine IL-40 is produced by activated neutrophils and plays a role in the early stages of seropositive rheumatoid arthritis
por: Navrátilová, Adéla, et al.
Publicado: (2023)

IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibodies, and NETosis
por: Navrátilová, Adela, et al.
Publicado: (2021)

Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
por: Kvasnička, Aleš, et al.
Publicado: (2023)

Evaluation of the Influence of Genetic Variants of SLC2A9 (GLUT9) and SLC22A12 (URAT1) on the Development of Hyperuricemia and Gout
por: Pavelcova, Katerina, et al.
Publicado: (2020)

Progranulin Is Associated with Disease Activity in Patients with Rheumatoid Arthritis
por: Andrés Cerezo, Lucie, et al.
Publicado: (2015)

Complex Analysis of Urate Transporters SLC2A9, SLC22A12 and Functional Characterization of Non-Synonymous Allelic Variants of GLUT9 in the Czech Population: No Evidence of Effect on Hyperuricemia and Gout
por: Hurba, Olha, et al.
Publicado: (2014)

Circulating microRNA alternations in primary hyperuricemia and gout
por: Bohatá, Jana, et al.
Publicado: (2021)

Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis
por: Levitova, Andrea, et al.
Publicado: (2016)

Interleukin 35 Synovial Fluid Levels Are Associated with Disease Activity of Rheumatoid Arthritis
por: Šenolt, Ladislav, et al.
Publicado: (2015)

Functional Characterization of Clinically-Relevant Rare Variants in ABCG2 Identified in a Gout and Hyperuricemia Cohort
por: Toyoda, Yu, et al.
Publicado: (2019)

S100A11 (calgizzarin) is released via NETosis in rheumatoid arthritis (RA) and stimulates IL-6 and TNF secretion by neutrophils
por: Navrátilová, Adéla, et al.
Publicado: (2021)

S100A4 is elevated in axial spondyloarthritis: a potential link to disease severity
por: Šumová, Barbora, et al.
Publicado: (2020)

Decreased Circulating Visfatin Is Associated with Improved Disease Activity in Early Rheumatoid Arthritis: Data from the PERAC Cohort
por: Sglunda, Ondřej, et al.
Publicado: (2014)

Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study
por: Závada, Jakub, et al.
Publicado: (2015)

Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin
por: Štorkánová, Hana, et al.
Publicado: (2021)

Correction: Štorkánová et al. Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin. Biomedicines 2021, 9, 650
por: Štorkánová, Hana, et al.
Publicado: (2023)

Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis
por: Andrés Cerezo, Lucie, et al.
Publicado: (2011)

Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis
por: Hurnakova, Jana, et al.
Publicado: (2015)

Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission
por: Hurnakova, Jana, et al.
Publicado: (2016)

Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study
por: Hurnakova, Jana, et al.
Publicado: (2017)

Metabolic Syndrome, Alcohol Consumption and Genetic Factors Are Associated with Serum Uric Acid Concentration
por: Stibůrková, Blanka, et al.
Publicado: (2014)

Pentosidine, an Advanced Glycation End-Product, May Reflect Clinical and Morphological Features of Hand Osteoarthritis
por: Braun, Martin, et al.
Publicado: (2012)

Chemokine and Cytokine Profiles in Patients with Hand Osteoarthritis
por: Baloun, Jiří, et al.
Publicado: (2020)

Resistin in idiopathic inflammatory myopathies
por: Filková, Mária, et al.
Publicado: (2012)

Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis
por: Andrés Cerezo, Lucie, et al.
Publicado: (2017)

The metastasis promoting protein S100A4 levels associate with disease activity rather than cancer development in patients with idiopathic inflammatory myopathies
por: Pleštilová, Lenka, et al.
Publicado: (2014)

Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2
por: Toyoda, Yu, et al.
Publicado: (2019)

Menopausal Transition: Prospective Study of Estrogen Status, Circulating MicroRNAs, and Biomarkers of Bone Metabolism
por: Baloun, Jiri, et al.
Publicado: (2022)

Lower serum clusterin levels in patients with erosive hand osteoarthritis are associated with more pain
por: Kropáčková, Tereza, et al.
Publicado: (2018)

Association between circulating miRNAs and spinal involvement in patients with axial spondyloarthritis
por: Prajzlerová, Klára, et al.
Publicado: (2017)

Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
por: Štorkánová, Hana, et al.
Publicado: (2021)

Switching first-line targeted therapy after not reaching low disease activity within 6 months is superior to conservative approach: a propensity score-matched analysis from the ATTRA registry
por: Nekvindová, Lucie, et al.
Publicado: (2021)

Female Sexual Dysfunction and Pelvic Floor Muscle Function Associated with Systemic Sclerosis: A Cross-Sectional Study
por: Heřmánková, Barbora, et al.
Publicado: (2022)

Functional Characterization of Rare Variants in OAT1/SLC22A6 and OAT3/SLC22A8 Urate Transporters Identified in a Gout and Hyperuricemia Cohort
por: Vávra, Jiří, et al.
Publicado: (2022)

Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout
por: Toyoda, Yu, et al.
Publicado: (2021)

Effect of an 8-Week Tailored Physiotherapy Program on Sexual Health in Women with Scleroderma and Myositis: A Controlled Pilot Study
por: Heřmánková, Barbora, et al.
Publicado: (2023)

Interleukin 37 limits monosodium urate crystal-induced innate immune responses in human and murine models of gout
por: Liu, Lei, et al.
Publicado: (2016)

Cross-sectional study of patients with axial spondyloarthritis fulfilling imaging arm of ASAS classification criteria: baseline clinical characteristics and subset differences in a single-centre cohort
por: Bubová, Kristyna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4ajg4k6vm1l9ck86ioqckjc2qn